Menger, J. M., Sathianathen, R. S., Sakamoto, K. M., & Hijiya, N. (2024). BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach. Current Oncology Reports, 26(3), 250–257. https://doi.org/10.1007/s11912-024-01502-z

Lee, M. H., Song, A., & Li, J. Y. (2024). Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report. Diagnostic Pathology, 19(1). https://doi.org/10.1186/s13000-024-01446-9

Hitzler, J., Alonzo, T., Gerbing, R., Beckman, A., Hirsch, B., Raimondi, S., Chisholm, K., Viola, S., Brodersen, L., Loken, M., Tong, S., Druley, T., O’Brien, M., Hijiya, N., Heerema-McKenney, A., Wang, Y.-C., Shore, R., Taub, J., Gamis, A., … Berman, J. N. (2021). High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial. Blood, 138(23), 2337–2346. https://doi.org/10.1182/blood.2021012206